Tamela Stuchiner

Quality of life among injectable and oral disease-modifying therapy users in the Pacific Northwest Multiple Sclerosis Registry

S. Cohan, Tamela L Stuchiner, Lindsay Lucas, 2020, BMC Neurology.

Results of sustained long-term use of interferon beta-1a in a community-based cohort of patients with relapsing multiple sclerosis

S. Cohan, Tamela L Stuchiner, E. Baraban, 2015, Journal of drug assessment.

The natural history of ALS: Baseline characteristics from a multicenter clinical cohort

M. Bind, T. Heiman-Patterson, N. Olney, 2023, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Telehealth Stroke Dysphagia Evaluation Is Safe and Effective

L. Yanase, Kathryn Morrell, M. Hyers, 2017, Cerebrovascular Diseases.

Three-year clinical outcomes of relapsing multiple sclerosis patients treated with dimethyl fumarate in a United States community health center

S. Cohan, Lindsay Lucas, K. Spinelli, 2018, Multiple sclerosis.

MRI utility in the detection of disease activity in clinically stable patients with multiple sclerosis: a retrospective analysis of a community based cohort

S. Cohan, Tamela L Stuchiner, E. Baraban, 2016, BMC Neurology.

Advancing Care and Outcomes for African American Patients With Multiple Sclerosis

S. Cohan, Tamela L Stuchiner, E. Baraban, 2022, Neurology.